Pieris issues special voting preferred to Chairman to secure authorized share increase vote

PALVELLA THERAPEUTICS, INC.

Issued 1 share of Series F Preferred to Chairman James Geraghty for $1 cash; preferred has 25M votes.
Preferred votes only on proposal to increase authorized common shares, in proportion to common votes.
No conversion, dividends, or liquidation rights; redeemable for $0.01 upon authorized share increase or Board order.
The authorized share increase is to facilitate the proposed merger with Palvella Therapeutics.
The preferred ensures a favorable vote on the authorized share increase, a key step in the merger.

item 1.01 item 5.03 item 3.02 item 3.03 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.